Mercaptamine

2 trials 1 recruiting AGastroenterology

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

0 Completed trials

1 Sponsors

1 Countries

Phase II

Phase II: 2

Sponsors using this IMP

National Institute For Infectious Diseases Lazzaro Spallanzani 2

All trials

2 total

Cysteamine in association with standard therapy for the treatment of hospitalized patients with COVID-19 pneumonia: phase 2 study on safety … Pending

2024-516800-40-00 Phase II 1 country National Institute For Infectious Diseases Lazzaro Spallanzani
Phase II study on the safety and efficacy of cysteamine in association with standard tuberculosis therapy for the treatment of patients with… Recruiting

2024-516088-10-00 Phase II 1 country National Institute For Infectious Diseases Lazzaro Spallanzani

Showing 1–2 of 2 trials

← All drugs A–Z